Loading
Latest filing published 09 Feb 2022 for Cardiovascular Systems Inc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by David Whitescarver on record concern Cardiovascular Systems Inc, in the capacity of senior executive. We count 5 filings; the first trade dates from 9 August 2021 and the latest from 8 February 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 9 February 2022, reports a share grant in Cardiovascular Systems Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations